Nelarabine in combination with intensive modified BFM AALL00P2: A pilot study for the treatment of high risk T-ALL a report from the Children's Oncology Group

被引：0
|
作者：
Dunsmore, K. [1 ]
Devidas, M. [1 ]
Borowitz, M. J. [1 ]
Winick, N. [1 ]
Hunger, S. P. [1 ]
Carroll, W. L. [1 ]
Camitta, B. M. [1 ]
机构：
[1] Childrens Oncol Grp, Arcadia, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.10002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10002
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Treatment-Related Mortality Contributes to Inferior Outcomes After Hematopoietic Stem Cell Transplant (HSCT) for Patients with T-Cell ALL: A Report From Children's Oncology Group AALL0434
    Winter, S.
    Devidas, M.
    Wood, B.
    Chen, Z.
    Esiashvili, N.
    Asselin, B.
    Loh, M.
    Rabin, K.
    Raetz, E.
    Zweidler-McKay, P.
    Schultz, K.
    Winick, N.
    Carroll, W.
    Hunger, S.
    Dunsmore, K.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S290 - S291
  • [42] A phase 3 trial of inotuzumab ozogamicin for high-risk B-ALL: Second safety phase results from Children's Oncology Group AALL1732
    O'Brien, Maureen Megan
    McNeer, Jennifer Lynn
    Rheingold, Susan R.
    Devidas, Meenakshi
    Chen, Zhiguo
    Bhojwani, Deepa
    Ramsey, Laura B.
    Agrawal, Anurag
    Wood, Brent L.
    Suh, Eugene
    Alexander, Sarah
    Miller, Tamara P.
    Militano, Olga
    Burke, Michael
    Salzer, Wanda L.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children’s Oncology Group Study AALL0031
    K R Schultz
    M Devidas
    W P Bowman
    A Aledo
    W B Slayton
    H Sather
    H W Zheng
    S M Davies
    P S Gaynon
    M Trigg
    R Rutledge
    D Jorstad
    A J Carroll
    N Heerema
    N Winick
    M J Borowitz
    S P Hunger
    W L Carroll
    B Camitta
    Leukemia, 2014, 28 : 964 - 967
  • [44] FAMILY LIFE EVENTS IN THE FIRST YEAR AFTER DIAGNOSIS OF STANDARD RISK (SR) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A REPORT FROM CHILDREN'S ONCOLOGY GROUP (COG) AALL0331
    Lau, Samantha
    Balsamo, Lyn
    Devidas, Meenakshi
    Lu, Xiaomin
    Winick, Naomi
    Hunger, Stephen
    Carroll, William
    Maloney, Kelly
    Kadan-Lottick, Nina
    PEDIATRIC BLOOD & CANCER, 2012, 58 (07) : 1041 - 1041
  • [45] Improved early event free survival (EFS)in children with philadelphia chromosome-positive(Ph+) acute lymphoblastic leukemia (ALL) with intensive Imatinib in combination with high dose chemotherapy: Children's oncology group (COG) study AALL0031
    Schultz, Kirk R.
    Bowman, W. Paul
    Slayton, William
    Aledo, Alex
    Devidas, Meenakshi
    Sather, Harland
    Borwitz, Michael J.
    Davies, Stella M.
    Trigg, Michael
    Pasut, Bernice
    Jorstad, Dean
    Eslinger, Tammie
    Burden, Laura E.
    Wang, Chenguang
    Rutledge, Robert
    Gaynon, Paul S.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Winick, Naomi
    Hunger, Stephen
    Carroll, William L.
    Camitta, Bruc
    BLOOD, 2007, 110 (11) : 9A - 9A
  • [46] EMOTIONAL AND BEHAVIORAL FUNCTIONING IN THE FIRST YEAR AFTER DIAGNOSIS OF STANDARD RISK (SR) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A REPORT FROM CHILDREN'S ONCOLOGY GROUP (COG) AALL0331
    Myers, Regina
    Balsamo, Lyn
    Carroll, William
    Hunger, Stephen
    Winick, Naomi
    Devidas, Meenakshi
    Lu, Xiaomin
    Maloney, Kelly
    Kadan-Lottick, Nina
    PEDIATRIC BLOOD & CANCER, 2012, 58 (07) : 1040 - 1040
  • [47] A revised Children's Oncology Group (COG) neuroblastoma risk classification system: Report from the COG biology study ANBL00B1.
    Irwin, Meredith
    Naranjo, Arlene
    Cohn, Susan Lerner
    London, Wendy B.
    Gastier-Foster, Julie M.
    Maris, John M.
    Bagatell, Rochelle
    Park, Julie R.
    Hogarty, Michael D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] A Revised Children's Oncology Group (COG) Neuroblastoma Risk Classification System: A Report from the COG Biology Study ANBL00B1
    Irwin, M.
    Naranjo, A.
    Cohn, S.
    London, W.
    Gastier-Foster, J.
    Maris, J.
    Bagatell, R.
    Park, J.
    Hogarty, M.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S53 - S54
  • [49] Changes in T-cell repertoire during high-risk neuroblastoma therapy: A report from the Children's Oncology Group
    Jiang, Yiyue
    Nabbi, Arash
    Danesh, Arnavaz
    Pedersen, Stephanie
    Eagles, Jenna
    Naranjo, Arlene
    Tan, Kai
    Collins, Natalie
    DuBois, Steven G.
    Bagatell, Rochelle
    Crompton, Brian D.
    Pugh, Trevor J.
    CANCER RESEARCH, 2024, 84 (17)
  • [50] Effect of dexamethasone (DEX) dose modification on osteonecrosis (ON) risk associated with intensified therapies for standard risk acute lymphoblastic leukemia (SR-ALL): A report from the Children's Oncology Group (COG) study AALL0331.
    Mattano, Leonard A.
    Devidas, Meenakshi
    Friedmann, Alison M.
    Raetz, Elizabeth A.
    Hunger, Stephen
    Winick, Naomi Joan
    Carroll, William L.
    Maloney, Kelly W.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345